Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Liabilities ₹11,173 Cr₹10,611 Cr₹8,778 Cr₹7,834 Cr₹6,496 Cr

What is the latest Total Liabilities ratio of GLAND PHARMA ?

The latest Total Liabilities ratio of GLAND PHARMA is ₹11,173 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹11,173 Cr
Mar2024₹10,611 Cr
Mar2023₹8,778 Cr
Mar2022₹7,834 Cr
Mar2021₹6,496 Cr

How is Total Liabilities of GLAND PHARMA Trending?

Years Total Liabilities % Change
Mar2025 ₹11,173 Cr
5.30
Mar2024 ₹10,611 Cr
20.89
Mar2023 ₹8,778 Cr
12.05
Mar2022 ₹7,834 Cr
20.59
Mar2021 ₹6,496 Cr -

Compare Total Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹36,267.0 Cr -0.6% -1% 30.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,794.0 Cr 1.7% -2.3% 8% Stock Analytics
DIVIS LABORATORIES ₹178,956.0 Cr 2% -2.2% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,820.0 Cr -1.8% -0.1% 36.7% Stock Analytics
CIPLA ₹109,370.0 Cr -2% -3.3% -9.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,133.0 Cr -0.6% -3.8% -6.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.6%

-1%

30.3%

SENSEX

1.7%

2.1%

-6%


You may also like the below Video Courses